Expression of Prooncogenic Nuclear Receptor 4A (NR4A)-Regulated Genes β1-Integrin and G9a Inhibited by Dual NR4A1/2 Ligands
Bis-indole-derived compounds including 1,1-bis(3'-indolyl)-1-(3,5-disubstitutedphenyl)methane (DIM-3,5) analogs bind both orphan nuclear receptors 4A1 (NR4A1) and NR4A2, and DIM-3,5 compounds act as dual receptor inverse agonists and inhibit both NR4A1- and NR4A2-regulated responses. Chromatin immunoprecipitation assays show that β1-integrin and the methyltransferase gene G9a are regulated by both NR4A1 and NR4A2 acting as cofactors for Sp1- and Sp4-dependent gene expression. DIM-3,5 treatment results in the loss of one or more of these nuclear factors from the β1-integrin and G9a promoters. Single-cell and RNAseq analyses show that both receptors regulate common (<10%) and unique genes in SW480 colon cancer cells; however, functional enrichment analysis of the differentially expressed genes converges to several common pathways and gene ontology terms.
Authors
- Lei Zhang (ORCID: https://orcid.org/0000-0002-7781-3478)
- Robert S. Chapkin (ORCID: https://orcid.org/0000-0002-6515-3898)
- Stephen H Safe (ORCID: https://orcid.org/0000-0002-2115-3060)
- Shreyan Gupta (ORCID: https://orcid.org/0000-0002-1904-9862)
- James J. Cai (ORCID: https://orcid.org/0000-0002-8081-6725)
- Michael L. Salinas (ORCID: https://orcid.org/0000-0001-5609-3996)
- Selim Romero (ORCID: https://orcid.org/0000-0002-2401-6272)
- Victoria Gatlin (ORCID: https://orcid.org/0009-0002-5887-2314)
Institutions
- Texas A&M University (US)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2025-04-21
- DOI
- https://doi.org/10.3390/ijms26083909
- Primary Topic
- Nuclear Receptors and Signaling
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- Cancer Prevention and Research Institute of Texas
- National Institutes of Health